Laukkanen et al., in a prospective study of 905 middle-aged men without heart failure, proved that NT-proANP could be considered as at least as strong a risk predictor as NT-proBNP in predicting death and the incidence of atrial fibrillation or heart failure [17]. This evidence concerns the gene NPPB and heart failure.